<DOC>
	<DOCNO>NCT02792842</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety ART-123 prevention cancer treatment relate symptom patient postoperative stage II / III colon cancer .</brief_summary>
	<brief_title>Exploratory Study ART-123 Prevention Cancer Treatment Related Symptoms Patients With Postoperative Stage II / III Colon Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>Main Diagnosed stage II / III colon cancer Deemed undergone curative A ( Cur A ) surgery Planning undergo postoperative adjuvant chemotherapy Main Have history hypersensitivity ingredient thrombomodulin alfa ( recombinant ) Have treatment history systemic chemotherapy ( include drug clinical trial stage ) radiotherapy With active double cancer</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>